抗糖尿病药物的全球市场调查报告-产业分析，规模，占有率，成长，趋势，2022年～2028年前的预测

Value Market Research深入调查抗糖尿病药物的全球市场，并预测未来几年行业将出现显着增长。本研究报告提供全球抗糖尿病药物市场相关之完全产业分析，提供市场规模、市场占有率、增长趋势、2023年至2028年的预测等。该报告以详细的市场介绍和突出报告关键增长数据的执行摘要为首。接续的章节讨论市场价值链、波特五力模型和市场吸引力分析。同时还设立关于COVID-19影响分析的独立章节，以了解市场如何应对疫情。

本报告的市场动态部分详细介绍了当前的市场推动因素/阻碍、课题/风险和未来机遇。本节对企业战略家和新产品开发部门非常有用。抗糖尿病药物全球市场调查将市场细分化，并根据收益和/或销售额的视点提供市场规模。该数据地区细分，同时国家/地区细分。数据是通过深入的初级访谈和世界各地的行业专家收集而来。详细的调查方法可以在样本报告中找到。这些市场预测受到最新的社会、政治和经济变化以及影响该抗糖尿病药物市场的当前市场动态所影响。

抗糖尿病药物市场报告的子章节提供市场竞争力调查，提供一些领先的市场参与者/製造商简介。这些章节涵括可深入了解竞争对手的产品线、财务状况、最新发展以及在行业中拥有最高市场占有率公司所需的丰富资讯。

本报告的观察对象国家如下列。

北美:美国，加拿大，墨西哥

欧洲:英国，德国，法国，义大利，俄罗斯，西班牙，其他的欧洲地区

亚太地区:中国，印度，日本，韩国，澳洲，其他APAC的各国

南美:巴西，阿根廷，秘鲁，智利及其他的南美各国

中东·非洲地区:沙乌地阿拉伯，UAE，以色列，南非

本报告的市场区隔如下列。

各产品

胰岛素(速效型，长时间型，预混合料胰岛素，短时间型，中间活性型)

药物类别(α-葡萄糖甘□抑製剂，双胍系药物，磺酰尿素类系药物，GLP-1(胰高血糖素样□)促效剂，DPP-IV(Dipeptidyl Peptidase)抑制剂，类格列汀，SGLT-II(钠葡萄糖运输蛋白质)抑制剂，胰岛素增敏剂)群

患者层

儿童

成人

老年

各给药途径

胰岛素注射器/胰岛素笔针

胰岛素帮浦

静脉内注射

口服

其他

目录

第1章 序文

• 本报告的内容
  • 目的
  • 主要读者
  • 独特的销售主张(USP)和报价环
• 调查范围
• 调查手法
  • 市场调查流程
  • 市场调查手法

第2章 摘要整理

• 市场概况
• 全球市场概述

第3章 抗糖尿病药物:产业分析

• 简介- 市场动态
• 推动市场要素
• 阻碍市场要素
• 商机
• 产业趋势
• 波特的五力分析
• 市场魅力分析
  • 各产品市场魅力分析
  • 各患者数的市场魅力分析
  • 各给药途径市场魅力分析
  • 各地区市场魅力分析

第4章 价值链分析

• 价值链分析
• 原料的分析
  • 原料的清单
  • 原料的製造原清单
  • 主要原料的价格趋势
• 潜在的买主清单
• 销售管道
  • 直销
  • 间接行销
  • 行销流通管道的新兴国家市场开拓趋势

第5章 COVID-19发生的影响分析

• COVID-19发生影响分析
  • 对生产的直接性影响
  • 供应链与市场的混乱
  • 对企业及金融市场的财务的影响
• COVID-19生产，进口，出口，各需求的影响分析
• 市场COVID-19发生前/发生后
• 冠状病毒(COVID-19)流行的影响预测
• COVID-19:微观和宏观的要素分析

第6章 抗糖尿病药物的全球市场分析:各产品

• 各产品概要
• 实际成果资料与预测资料
• 各产品分析
• 胰岛素(速效型类比，长时间型类比，预混合料胰岛素，短时间型类比，中间活性型胰岛素)各区域销售额实际成果与预测
• 药物类别(α-葡萄糖甘□抑製剂，双胍系，Sulfonylureas系，GLP-1(胰高血糖素样□)促效剂，DPP-IV(Dipeptidyl Peptidase)抑制剂，类格列汀，SGLT-II(钠葡萄糖运输蛋白质)抑制剂，胰岛素增敏剂)各地区的销售额实际成果与预测

第7章 抗糖尿病药物的全球市场分析:患者层

• 患者层概要
• 历史的资料与预测资料
• 患者层分析
• 儿童:各区域销售额实际成果与预测
• 成人病的各区域销售额实际成果与预测
• 老年期的各区域销售额实际成果与预测

第8章 抗糖尿病药物的全球市场销售额分析:各给药途径

• 各给药途径概要
• 实际成果资料与预测资料
• 各给药途径分析
• 胰岛素注射器/胰岛素笔针的各区域销售额实际成果与预测
• 胰岛素帮浦各区域销售额实际成果与预测
• 点滴的各区域销售额实际成果与预测
• 口服剂各区域销售额实际成果与预测
• 其他的各区域销售额实际成果与预测

第9章 抗糖尿病药物的全球市场销售额分析:各地区

• 各地区展望销售额分析
• 简介销售额分析
• 北美的销售额分析
  • 概要，销售额转变，销售额预测分析
  • 北美各市场区隔销售额分析
  • 北美:各国销售额分析
  • 美国的销售额分析
  • 加拿大的销售额分析
  • 墨西哥的销售额分析
• 欧洲的销售额分析
  • 概要，过去与未来的销售额分析
  • 欧洲的各市场区隔销售额分析
  • 欧洲:各国销售额分析
  • 英国的销售额分析
  • 法国的销售额分析
  • 德国的销售额分析
  • 义大利的销售额分析
  • 俄罗斯的销售额分析
  • 其他欧洲的销售额分析
• 亚太地区的销售额分析
  • 概要，过去与未来的销售额分析
  • 亚太地区的各市场区隔销售额分析
  • 亚太地区的各国销售额分析
  • 中国的销售额分析
  • 印度的销售额分析
  • 日本的销售额分析
  • 韩国的销售额分析
  • 澳洲的销售额分析
  • 其他亚太地区的销售额分析
• 南美的销售额分析
  • 概要，过去与未来的销售额分析
  • 南美的各市场区隔销售额分析
  • 南美:各国销售额分析
  • 巴西的销售额分析
  • 阿根廷的销售额分析
  • 秘鲁的销售额分析
  • 智利的销售额分析
  • 其他南美国家的销售额分析
• 中东·非洲的销售额分析
  • 概要，过去与未来的销售额分析
  • 中东·非洲地区各市场区隔销售额分析
  • 中东·非洲各国销售额分析
  • 沙乌地阿拉伯的销售额分析
  • UAE的销售额分析
  • 以色列的销售额分析
  • 南非的销售额分析
  • 其他中东·非洲地区的销售额分析

第10章 抗糖尿病药物企业的竞争情形

• 抗糖尿病药物市场竞争
• 联盟·合作·协定
• 合併·收购
• 新产品的上市
• 其他的开发

第11章 企业简介

• 前十大企业的占有率分析
• 市场集中度
• AstraZeneca
  • 企业概要
  • 企业收益
  • 产品介绍
  • 最近的开发情形
• Novartis AG
  • 公司概要
  • 企业收益
  • 产品资讯
  • 最近的开发情形
• Johnson & Johnson
  • 公司概要
  • 企业收益
  • 产品资讯
  • 最近的开发情形
• Merck & Co. Inc.
  • 公司概要
  • 企业收益
  • 产品资讯
  • 最近的开发情形
• Pfizer
  • 公司概要
  • 企业收益
  • 产品资讯
  • 最近的开发情形
• Sanofi
  • 公司概要
  • 企业收益
  • 产品资讯
  • 最近的趋势

在公司简介中，财务细节和最近的发展基于可取得的现有信息，可能不包含非上市公司。

Value Market Research deeply researched the Global Antidiabetics Market to foresee a significant growth in the industry over the upcoming years. The global antidiabetics market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global antidiabetics market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this antidiabetics market.

The next sections of the antidiabetics market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America: United States, Canada, and Mexico

Europe: United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific: China, India, Japan, South Korea, Australia & Rest of APAC

Latin America: Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa: Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below:

By Product

Insulin (Rapid Acting Analog, Long Acting Analog, Premixed insulin, Short Acting Analog, Intermediate Acting Insulin)

Drug Class (Alpha Glucosidase Inhibitors, Biguanides, Sulphonylureas, GLP-1 (Glucagon like peptide) Agonists, DPP-IV (Dipeptidyl Peptidase) inhibitors, Meglitinides, SGLT-II (Sodium Glucose Transport Proteins) inhibitors, Thiazolidinedione)

By Patient Population

Pediatric

Adult

Geriatric

By Route Of Administration

Insulin Syringe/ Insulin Pen

Insulin Pump

Intravenous Infusion

Oral

Others

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . ANTIDIABETICS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Patient Population
  • 3.7.3 Market Attractiveness Analysis By Route Of Administration
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

• 5.1. Impact Analysis of Covid-19 Outbreak
  • 5.1.1. Direct Impact on Production
  • 5.1.2. Supply Chain and Market Disruption
  • 5.1.3. Financial Impact on Firms and Financial Markets
• 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
• 5.3. Market: Pre V/S Post COVID-19
• 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
• 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL ANTIDIABETICS MARKET ANALYSIS BY PRODUCT

• 6.1 Overview by Product
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Product
• 6.4 Insulin (Rapid Acting Analog, Long Acting Analog, Premixed Insulin, Short Acting Analog, Intermediate Acting Insulin) Historic and Forecast Sales by Regions
• 6.5 Drug Class (Alpha Glucosidase Inhibitors, Biguanides, Sulphonylureas, GLP-1 (Glucagon Like Peptide) Agonists, DPP-IV (Dipeptidyl Peptidase) Inhibitors, Meglitinides, SGLT-II (Sodium Glucose Transport Proteins) Inhibitors, Thiazolidinedione) Historic and Forecast Sales by Regions

7 . GLOBAL ANTIDIABETICS MARKET ANALYSIS BY PATIENT POPULATION

• 7.1 Overview by Patient Population
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Patient Population
• 7.4 Pediatric Historic and Forecast Sales by Regions
• 7.5 Adult Historic and Forecast Sales by Regions
• 7.6 Geriatric Historic and Forecast Sales by Regions

8 . GLOBAL ANTIDIABETICS MARKET SALES ANALYSIS BY ROUTE OF ADMINISTRATION

• 8.1 Overview by Route Of Administration
• 8.2 Historical and Forecast Data
• 8.3 Analysis by Route Of Administration
• 8.4 Insulin Syringe/ Insulin Pen Historic and Forecast Sales by Regions
• 8.5 Insulin Pump Historic and Forecast Sales by Regions
• 8.6 Intravenous Infusion Historic and Forecast Sales by Regions
• 8.7 Oral Historic and Forecast Sales by Regions
• 8.8 Others Historic and Forecast Sales by Regions

9 . GLOBAL ANTIDIABETICS MARKET SALES ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook Sales Analysis
• 9.2. Introduction Sales Analysis
• 9.3. North America Sales Analysis
  • 9.3.1. Overview, Historic and Forecast Sales Analysis
  • 9.3.2. North America By Segment Sales Analysis
  • 9.3.3. North America By Country Sales Analysis
  • 9.3.4. United State Sales Analysis
  • 9.3.5. Canada Sales Analysis
  • 9.3.6. Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1. Overview, Historic and Forecast Sales Analysis
  • 9.4.2. Europe by Segment Sales Analysis
  • 9.4.3. Europe by Country Sales Analysis
  • 9.4.4. United Kingdom Sales Analysis
  • 9.4.5. France Sales Analysis
  • 9.4.6. Germany Sales Analysis
  • 9.4.7. Italy Sales Analysis
  • 9.4.8. Russia Sales Analysis
  • 9.4.9. Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1. Overview, Historic and Forecast Sales Analysis
  • 9.5.2. Asia Pacific by Segment Sales Analysis
  • 9.5.3. Asia Pacific by Country Sales Analysis
  • 9.5.4. China Sales Analysis
  • 9.5.5. India Sales Analysis
  • 9.5.6. Japan Sales Analysis
  • 9.5.7. South Korea Sales Analysis
  • 9.5.8. Australia Sales Analysis
  • 9.5.9. Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1. Overview, Historic and Forecast Sales Analysis
  • 9.6.2. Latin America by Segment Sales Analysis
  • 9.6.3. Latin America by Country Sales Analysis
  • 9.6.4. Brazil Sales Analysis
  • 9.6.5. Argentina Sales Analysis
  • 9.6.6. Peru Sales Analysis
  • 9.6.7. Chile Sales Analysis
  • 9.6.8. Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1. Overview, Historic and Forecast Sales Analysis
  • 9.7.2. Middle East & Africa by Segment Sales Analysis
  • 9.7.3. Middle East & Africa by Country Sales Analysis
  • 9.7.4. Saudi Arabia Sales Analysis
  • 9.7.5. UAE Sales Analysis
  • 9.7.6. Israel Sales Analysis
  • 9.7.7. South Africa Sales Analysis
  • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE ANTIDIABETICS COMPANIES

• 10.1. Antidiabetics Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11 . COMPANY PROFILES OF ANTIDIABETICS INDUSTRY

• 11.1. Top 10 Company Share Analysis
• 11.2. Market Concentration Rate
• 11.3. AstraZeneca
  • 11.3.1. Company Overview
  • 11.3.2. Company Revenue
  • 11.3.3. Products
  • 11.3.4. Recent Developments
• 11.4. Novartis AG
  • 11.4.1. Company Overview
  • 11.4.2. Company Revenue
  • 11.4.3. Products
  • 11.4.4. Recent Developments
• 11.5. Johnson & Johnson
  • 11.5.1. Company Overview
  • 11.5.2. Company Revenue
  • 11.5.3. Products
  • 11.5.4. Recent Developments
• 11.6. Merck & Co. Inc.
  • 11.6.1. Company Overview
  • 11.6.2. Company Revenue
  • 11.6.3. Products
  • 11.6.4. Recent Developments
• 11.7. Pfizer
  • 11.7.1. Company Overview
  • 11.7.2. Company Revenue
  • 11.7.3. Products
  • 11.7.4. Recent Developments
• 11.8. Sanofi
  • 11.8.1. Company Overview
  • 11.8.2. Company Revenue
  • 11.8.3. Products
  • 11.8.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• COVID-19 Impact Analysis by Production, Import, Export and Demand
• Pre V/S Post COVID-19
• Estimated Impact Of The Coronavirus (Covid-19) Epidemic
• COVID-19: Micro and Macro Factor Analysis
• Analysis by Product (USD MN)
• Insulin (Rapid Acting Analog, Long Acting Analog, Premixed Insulin, Short Acting Analog, Intermediate Acting Insulin) Market Sales by Geography (USD MN)
• Drug Class (Alpha Glucosidase Inhibitors, Biguanides, Sulphonylureas, GLP-1 (Glucagon Like Peptide) Agonists, DPP-IV (Dipeptidyl Peptidase) Inhibitors, Meglitinides, SGLT-II (Sodium Glucose Transport Proteins) Inhibitors, Thiazolidinedione) Market Sales by Geography (USD MN)
• Analysis Market by Patient Population (USD MN)
• Pediatric Market Sales by Geography (USD MN)
• Adult Market Sales by Geography (USD MN)
• Geriatric Market Sales by Geography (USD MN)
• Analysis by Route Of Administration (USD MN)
• Insulin Syringe/ Insulin Pen Market Sales by Geography (USD MN)
• Insulin Pump Market Sales by Geography (USD MN)
• Intravenous Infusion Market Sales by Geography (USD MN)
• Oral Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Antidiabetics Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Antidiabetics Report
• Market Research Process
• Market Research Methodology
• Global Antidiabetics Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product
• Market Attractiveness Analysis by Patient Population
• Market Attractiveness Analysis by Route Of Administration
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product (USD MN)
• Insulin (Rapid Acting Analog, Long Acting Analog, Premixed Insulin, Short Acting Analog, Intermediate Acting Insulin) Market Sales by Geography (USD MN)
• Drug Class (Alpha Glucosidase Inhibitors, Biguanides, Sulphonylureas, GLP-1 (Glucagon Like Peptide) Agonists, DPP-IV (Dipeptidyl Peptidase) Inhibitors, Meglitinides, SGLT-II (Sodium Glucose Transport Proteins) Inhibitors, Thiazolidinedione) Market Sales by Geography (USD MN)
• Global Market Analysis by Patient Population (USD MN)
• Pediatric Market Sales by Geography (USD MN)
• Adult Market Sales by Geography (USD MN)
• Geriatric Market Sales by Geography (USD MN)
• Global Market Analysis by Route Of Administration (USD MN)
• Insulin Syringe/ Insulin Pen Market Sales by Geography (USD MN)
• Insulin Pump Market Sales by Geography (USD MN)
• Intravenous Infusion Market Sales by Geography (USD MN)
• Oral Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.